SCHEMBL30906408

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C

nearest known ligand 0.69

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	RXFP1	Q9HBX9	6/20	0.69

▸	PTH1R	Q03431	8/20	0.66

▸	GLP1R	P43220	5/20	0.66

▸	CCKBR	P32239	1/20	0.66

▸	ECE1	P42892	1/20	0.64

▸	MUS81	Q96NY9	1/20	0.64

▸	GRPR	P30550	1/20	0.64

▸	GCGR	P47871	1/20	0.62

▸	GIPR	P48546	1/20	0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31182558	0.92	RXFP1 (0.72)	RXFP1PTH1RGLP1RCCKBRECE1
SCHEMBL30906474	0.92	GLP1R (0.67)	RXFP1PTH1RGLP1RCCKBRECE1
SCHEMBL30013283	0.91	PTH1R (0.73)	RXFP1PTH1RGLP1RCCKBRECE1
SCHEMBL30658384	0.90	RXFP1 (0.71)	RXFP1PTH1RGLP1RCCKBR
SCHEMBL30906573	0.90	IL23R (0.68)	RXFP1GLP1RCCKBRECE1MUS81
SCHEMBL30906562	0.90	IL23R (0.68)	RXFP1GLP1RCCKBRECE1MUS81
SCHEMBL30658281	0.89	PTH1R (0.64)	RXFP1PTH1RGLP1RCCKBRECE1
SCHEMBL17940396	0.89	RXFP1 (0.72)	RXFP1PTH1RGLP1RCCKBRECE1
SCHEMBL29443912	0.89	RXFP1 (0.63)	RXFP1GLP1RECE1MUS81GRPR
SCHEMBL30906537	0.89	IL23R (0.69)	RXFP1GLP1RCCKBRECE1MUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed